<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
"http://www.w3.org/TR/html4/strict.dtd">
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>
	<!-- CSS
  ================================================== -->
	<link rel="stylesheet" href="/resources/stylesheets/layout.css">
	<link rel="stylesheet" href="/resources/stylesheets/content.css">
	<link rel="stylesheet" href="/resources/stylesheets/print.css">
	<link rel="stylesheet" href="/resources/stylesheets/font-awesome.css">

	<!-- Basic Page Needs
  ================================================== -->
    <script src="/resources/libraries/jquery-1.8.3.min.js" type="text/javascript"></script>
    <script type="text/x-mathjax-config">
	MathJax.Hub.Config({
	  "HTML-CSS": { linebreaks: { automatic: true } },
	         SVG: { linebreaks: { automatic: true } }
	});
	</script>
    <script type="text/javascript" async src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
	<meta charset="utf-8">
	<title>Musculoskeletal System</title>
	<meta name="description" content="Course Notes for Musculoskeletal System">
	<meta name="author" content="Kevan Lu">
	<meta name="robots" content="noindex,nofollow"/>
	
	<!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0"/>

	<script>
	  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
	  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
	  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	  })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

	  ga('create', 'UA-40381402-3', 'auto');
	  ga('send', 'pageview');
	</script>

	<!-- Favicons
	================================================== -->
	<link rel="shortcut icon" href="/references/favicon.png" type="image/png">

	<!-- iOS Icons
	================================================== -->
	<link href="/resources/images/icon-iphone.png" rel="apple-touch-icon"/>
	<link href="/resources/images/icon-ipad.png" rel="apple-touch-icon" sizes="76x76" />
	<link href="/resources/images/icon-iphone-retina.png" rel="apple-touch-icon" sizes="120x120"/>
	<link href="/resources/images/icon-ipad-retina.png" rel="apple-touch-icon" sizes="152x152" />
</head>
<body>
    <div id="home-overlay">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<div id="header-search-icon"><a id="header-search-button"><i class="fa fa-search"></i></a></div>
</div>
<div id="header-search-bar">
	<form class="search" action="http://www.schulichnotes.com/musculoskeletal/search.html">
	<div><input type="text" value="Search Musculoskeletal System" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	</form>
</div>
<div id="overlay"><h1><a style="border:none;" href="http://www.schulichnotes.com/musculoskeletal">Musculoskeletal System</a></h1></div>
    <div class="sidebar-background"></div>
    <div class="sidebar">
        <!-- Displays a Search Bar-->
<div class="search-wrapper">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<form class="search" action="http://www.schulichnotes.com/musculoskeletal/search.html">
	<div style="float: left;"><input type="text" value="Search Musculoskeletal System" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	<div style="float: left;"><input type="button" id="tipue_search_button" onclick="this.form.submit();"></div>
	<div style="clear: left;"></div>
	</form>
</div>

        <div class="course-toc">
            <div class="course-index">
                <a href="http://www.schulichnotes.com/musculoskeletal">Musculoskeletal System</a>
            </div>
            <nav>	
	<li class="week">Week 1</li>
	<ul>
		<li class="day">Monday, January 19</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/intro-msk.html">Introduction to the Musculoskeletal System</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/concepts-musculoskeletal-medicine.html">Concepts in Musculoskeletal Medicine</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/approach-spine.html">Approach to the Spine</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/anatomy-spine.html">Anatomy of the Spine</a></li></ul>
		<li class="day">Tuesday, January 20</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/approach-low-back-pain.html">Approach to Low Back Pain</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/imaging-low-back-pain-radiculopathy.html">Imaging with Low Back Pain &amp; Radiculopathy</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/injections-treatment-low-back-pain.html">Injections in the Treatment of Low Back Pain</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/anatomy-lab-back-spine.html">Anatomy Lab &ndash; Back and Spine</a></li></ul>
		<li class="day">Wednesday, January 21</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/anatomy-shoulder.html">Anatomy of the Shoulder</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/approach-shoulder.html">Approach to the Shoulder</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/anatomy-lab-posterior-shoulder.html">Anatomy Lab &ndash; Posterior Shoulder</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/anatomy-lab-pec-axilla.html">Anatomy Lab &ndash; Pec/Axilla</a></li></ul>
		<li class="day">Thursday, January 22</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/22/brachial-plexus.html">The Brachial Plexus</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/22/exercise-physiology.html">Exercise Physiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/22/anatomy-lab-brachial-plexus.html">Anatomy Lab &ndash; Brachial Plexus</a></li></ul>
		<li class="day">Friday, January 23</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/23/anatomy-arm.html">Anatomy of the Arm</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/23/anatomy-forearm.html">Anatomy of the Forearm</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/23/approach-arm-elbow.html">Approach to the Arm and Elbow</a></li></ul>
	</ul>
	<li class="week">Week 2</li>
	<ul>
		<li class="day">Monday, January 26</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/case-week-brachial-plexus.html">Case of the Week &ndash; Brachial Plexus Injury</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/nerve-injuries.html">Nerve Injuries</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/nerve-surgery-reconstruction.html">Nerve Surgery &amp; Reconstruction</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/anatomy-lab-anterior-forearm.html">Anatomy Lab &ndash; Anterior Forearm</a></li></ul>
		<li class="day">Tuesday, January 27</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/27/anatomy-hand.html">Anatomy of the Hand</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/27/work-injuries-wsib.html">Workplace Injuries and WSIB</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/27/anatomy-lab-posterior-forearm.html">Anatomy Lab &ndash; Posterior Forearm</a></li></ul>
		<li class="day">Wednesday, January 28</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/28/approach-arm-wrist-hand.html">Approach to the Arm, Wrist & Hand</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/28/msk-infections.html">MSK Infections</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/28/anatomy-lab-hand.html">Anatomy Lab &ndash; Hand</a></li></ul>
		<li class="day">Thursday, January 29</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/29/fractures-complications.html">Fractures &amp; Complications</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/29/fracture-imaging.html">Fracture Imaging</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/29/small-group-fractures.html">Fractures Small Group</a></li></ul>
		<li class="day">Friday, January 30</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/30/pharmacology-arachidonic-acid-derivatives.html">Pharmacology of Arachidonic Acid Deriatives &ndash; NSAIDs</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/30/cervical-soft-tissue-injuries.html">Cervical Soft Tissue Injuries</a></li></ul>
	</ul>
	<li class="week">Week 3</li>
	<ul>
		<li class="day">Monday, February 2</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/02/anatomy-lab-posterior-thigh.html">Anatomy Lab &ndash; Posterior Thigh</a></li></ul>
		<li class="day">Tuesday, February 3</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/03/pccm-week-1-upper-limb.html">PCCM Week 1 &ndash; Upper Limb</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/03/approach-hip.html">Approach to the Hip</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/03/anatomy-lab-anterior-medial-thigh.html">Anatomy Lab &ndash; Anterior &amp; Medial Thigh</a></li></ul>
		<li class="day">Wednesday, February 4</li>
		<ul></ul>
		<li class="day">Thursday, February 5</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/05/anatomy-lab-leg-knee.html">Anatomy Lab &ndash; Leg &amp; Knee</a></li></ul>
		<li class="day">Friday, February 6</li>
		<ul></ul>
	</ul>
	<li class="week">Week 4</li>
	<ul>
		<li class="day">Monday, February 9</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/09/anatomy-lab-foot-ankle.html">Anatomy Lab &ndash; Foot &amp; Ankle</a></li></ul>
		<li class="day">Tuesday, February 10</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/10/pediatric-orthopedics-1.html">Pediatric Orthopedics I</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/10/pediatric-orthopedics-2.html">Pediatric Orthopedics II</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/10/child-health-small-groups-child-limp.html">Child Health Small Groups &ndash; Limp</a></li></ul>
		<li class="day">Wednesday, February 11</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/11/common-complaints-primary-care.html">Common Complaints in Primary Care</a></li></ul>
		<li class="day">Thursday, February 12</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/12/soft-tissue-injury-small-groups.html">Soft Tissue Injuries Small Group</a></li></ul>
	</ul>
	<li class="week">Week 5</li>
	<ul>
		<li class="day">Tuesday, February 17</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/17/acute-monoarthritis.html">Acute Monoarthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/17/chronic-monoarthritis.html">Chronic Monoarthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/17/small-group-monoarthritis.html">Monoarthritis Small Group</a></li></ul>
		<li class="day">Wednesday, February 18</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/acute-polyarthritis.html">Acute Polyarthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/rheumatoid-arthritis.html">Rheumatoid Arthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/rheumatology-labs.html">Rheumatology Labs</a></li></ul>
		<li class="day">Thursday, February 19</li>
		<ul></ul>
		<li class="day">Friday, February 20</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/20/connective-tissue-disorders-1.html">Connective Tissue Disorders I</a></li></ul>
	</ul>
	<li class="week">Week 6</li>
	<ul>
		<li class="day">Monday, February 23</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/23/DMARDs-biologics.html">DMARDs &amp; Biologics</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/23/small-groups-polyarthritis.html">Polyarthritis Small Group</a></li></ul>
		<li class="day">Tuesday, February 24</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/24/rheumatology-review-jeopardy.html">Rheumatology Review Jeopardy</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/24/msk-clinical-review.html">MSK Clinical Review</a></li></ul>
		<li class="day">Wednesday, February 25</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/25/soft-tissue-tumours.html">Soft Tissue Tumours</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/25/bone-tumours.html">Bone Tumours</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/25/small-group-bone-tumour-pathology.html">Bone Tumour Pathology Small Group</a></li></ul>
	</ul>
</nav>
        </div>
    </div>
    <div class="content-offset">
        <div class="content-background"></div>
        <div class="content">
            <div class="single post">
                <!-- Post Layout -->
                <div class="title"><h1>Rheumatology Labs</h1></div>
                <info datetime="2015-02-18">
                    <span class="author"><a href="http://www.schulichnotes.com/about.html#kevanlu">Kevan Lu</a></span>
                    <span class="date">Wednesday, February 18, 2015</span>
                </info>
                <div class="body"><h2 id="lecture-objectives"><strong>Lecture Objectives</strong></h2>
<ol>
  <li><strong>Synovial Fluid</strong>
    <ol>
      <li>What routine tests should synovial fluid be sent for?</li>
      <li>What is the difference between normal, non-inflammatory, and inflammatory synovial fluid?</li>
      <li>What are the different features of inflammatory, crystalline, and infectious synovial fluid?</li>
    </ol>
  </li>
  <li><strong>Inflammatory Markers</strong>
    <ol>
      <li>What are the common serologic abnormalities which reveal an “inflammatory picture”?</li>
      <li>What is an Erythrocyte Sedimentation Rate (ESR)?</li>
      <li>What is a C-Reactive Protein (CRP)?</li>
    </ol>
  </li>
  <li><strong>Rheumatoid Factor</strong>
    <ol>
      <li>Is a rheumatoid factor is necessary to make a diagnosis of rheumatoid arthritis?</li>
      <li>How many patients with early RA and with established RA will have a rheumatoid factor?</li>
      <li>What does the presence of a rheumatoid factor in rheumatoid arthritis actually mean?</li>
      <li>Simplistically, what is the basic immunologic structure of a rheumatoid factor?</li>
      <li>In what rheumatic and non-rheumatic diseases is a rheumatoid factor present?</li>
    </ol>
  </li>
  <li><strong>Anti-Nuclear Antibodies</strong>
    <ol>
      <li>Why is an anti-nuclear antibody a screening test for antibodies directed at “something” in the nucleus?</li>
      <li>What rheumatic and non-rheumatic diseases can the ANA be present in?</li>
      <li>Are patients with a negative ANA unlikely to have systemic lupus erythematosus?</li>
    </ol>
  </li>
  <li><strong>Other Antibodies</strong>
    <ol>
      <li>What are ds-DNA antibodies and the antibodies in the ENA panel anti-nuclear antibodies?</li>
      <li>Do all patients with SLE have to have a positive ds-DNA?</li>
      <li>What is an ANCA, what are the two types, and what diseases is it associated with?</li>
      <li>What antibodies are c-ANCA and p-ANCA a result of?</li>
      <li>Why do some patients with connective tissue disorders and vasculitis have a low complement level?</li>
    </ol>
  </li>
</ol>

<h1 id="synovial-fluid">Synovial Fluid</h1>
<hr />

<p><img class="right" src="/images/wn-girix.png" /></p>

<ul>
  <li>Produced by the synovial lining cells, and helps the surfaces of the cartilage slide together.</li>
  <li>Normally there’s only a few mL of fluid in the joint, but production increases with inflammation of the synovium.</li>
  <li>A joint should always be aspirated for fluid when you see an acute, hot, red joint.</li>
</ul>

<blockquote>
  <h4 id="objective"><strong>Objective</strong></h4>
  <ul>
    <li>What routine tests should synovial fluid be sent for?</li>
  </ul>
</blockquote>

<ul>
  <li>3 C’s and a G.
    <ol>
      <li><em>Cell Count &amp; Differential</em>.</li>
      <li><em>Crystals</em>.</li>
      <li><em>Culture &amp; Sensitivity</em>.</li>
      <li><em>Gram Stain</em>.</li>
    </ol>
  </li>
  <li>This is <i>ALL</i> you ever test synovial fluid for; if you’re ever asked to test protein, or RF, or anything like that, it’s useless!</li>
</ul>

<blockquote>
  <h4 id="objective-1"><strong>Objective</strong></h4>
  <ul>
    <li>What is the difference between normal, non-inflammatory, and inflammatory synovial fluid?</li>
  </ul>
</blockquote>

<p><img class="right" src="/images/b3uoab3j.png" /></p>

<ul>
  <li><em>Normal Fluid</em> → clear and straw coloured fluid.
    <ul>
      <li>Viscous like “egg-white”.</li>
    </ul>
  </li>
  <li><em>Non-Inflammatory Fluid</em> → remains clear.
    <ul>
      <li>Viscous like “egg white”.</li>
    </ul>
  </li>
  <li><em>Inflammatory/Infectious Fluid</em> → becomes <i>cloudy to opaque</i>, depending on the cell count.
    <ul>
      <li><i>Becomes more watery</i>; inflammation increases the water content of the fluid, making it less viscous.</li>
      <li>In an obvious infection, it may look like pus.</li>
      <li>Can be caused by infection, gout/pseudogout, or an autoimmune reaction.</li>
    </ul>
  </li>
  <li><strong>Findings on Cell Count</strong>:
    <ul>
      <li><em>Normal Fluid</em> → <script type="math/tex">% <![CDATA[
< 0.2 \times; 10^9 %]]></script> cells/Litre.</li>
      <li><em>Non-Inflammatory Fluid</em> → <script type="math/tex">0.2-2.0 \times 10^9</script> cells/Litre.</li>
      <li><em>Inflammatory Fluid</em>  → <script type="math/tex">>2.0 \times 10^9</script> cells/Litre.</li>
      <li><em>Infectious Fluid</em> → with an infection, the cell count can rise as high as <script type="math/tex">50-100 \times 10^9</script> cells/Litre!</li>
    </ul>
  </li>
  <li><strong>Findings on Cell Differential</strong>:
    <ul>
      <li><em>Normal Fluid</em> → &lt; 25% PMNs (Polymorphonuclear Neutrophils).</li>
      <li><em>Non-inflammatory Fluid</em> → &lt; 25% PMNs.</li>
      <li><em>Inflammatory/Infectious Fluids</em> → &gt;75% PMNs.</li>
    </ul>
  </li>
  <li><strong>Findings with Crystals</strong>:
    <ul>
      <li>If inflammation caused by <em>gout</em> → <em>monosodium urate</em>.</li>
      <li>If inflammation caused by <em>CPPD</em> → <em>calcium pyrophosphate</em>.
        <ul>
          <li>CPPD → Calcium pyrophosphate deposition disorder.</li>
          <li>Leads to both pseudogout and chondrocalcinosis.</li>
        </ul>
      </li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="summary-of-synovial-fluid-findings"><strong>Summary of Synovial Fluid Findings</strong></h4>

  <table>
    <thead>
      <tr>
        <th style="text-align: left"> </th>
        <th style="text-align: left">Normal</th>
        <th style="text-align: left">Non-Inflammatory</th>
        <th style="text-align: left">Inflammatory</th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td style="text-align: left">Colour</td>
        <td style="text-align: left">Clear</td>
        <td style="text-align: left">Clear</td>
        <td style="text-align: left"><em>Cloudy-Opaque</em></td>
      </tr>
      <tr>
        <td style="text-align: left">Viscosity</td>
        <td style="text-align: left">High</td>
        <td style="text-align: left">High</td>
        <td style="text-align: left"><em>Low</em></td>
      </tr>
      <tr>
        <td style="text-align: left">Cell Count (cells/L)</td>
        <td style="text-align: left"><script type="math/tex">% <![CDATA[
<0.2 \times 10^9 %]]></script></td>
        <td style="text-align: left"><script type="math/tex">0.2-2.0 \times 10^9</script></td>
        <td style="text-align: left"><script type="math/tex">>2.0 \times 10^9</script></td>
      </tr>
      <tr>
        <td style="text-align: left">Gram Stain</td>
        <td style="text-align: left">Negative</td>
        <td style="text-align: left">Negative</td>
        <td style="text-align: left">Positive if infectious</td>
      </tr>
      <tr>
        <td style="text-align: left">Culture</td>
        <td style="text-align: left">Negative</td>
        <td style="text-align: left">Negative</td>
        <td style="text-align: left">Positive if infectious</td>
      </tr>
      <tr>
        <td style="text-align: left">Crystals</td>
        <td style="text-align: left">Negative</td>
        <td style="text-align: left">Negative</td>
        <td style="text-align: left">Positive if gout or CPPD</td>
      </tr>
    </tbody>
  </table>
</blockquote>

<h1 id="inflammatory-markers">Inflammatory Markers</h1>
<hr />

<ul>
  <li>What blood tests give us a clue that something ‘inflammatory’ may be at play?
    <ul>
      <li>In other words, how do we differentiate an inflammatory vs degenerative cause?</li>
      <li>We can look for serologic markers of systemic inflammation!</li>
    </ul>
  </li>
  <li><strong>Serologic Markers of Inflammation</strong>:
    <ol>
      <li><em>CBC</em> → Hb, WBC, Plt.</li>
      <li><em>Acute Phase Reactants</em> (ARPs) → <i>ESR</i>, <i>CRP</i>, Ferritin, complement, immunoglobulins.</li>
    </ol>
  </li>
</ul>

<blockquote>
  <h4 id="objective-2"><strong>Objective</strong></h4>
  <ul>
    <li>What are the common serologic abnormalities which reveal an “inflammatory picture”?</li>
  </ul>
</blockquote>

<h2 id="findings-on-the-cbc"><strong>Findings on the CBC</strong></h2>
<ul>
  <li><strong>Hb</strong> → may see normocytic anemia with chronic inflammation. Recall, this was <i>Anemia of Chronic Inflammation</i>, which we saw in Blood!</li>
  <li><strong>WBC</strong> → infectious/crystalline causes of inflammation may result in <i>increased</i> WBC levels.
    <ul>
      <li>However, in inflammatory diseases like RA, WBCs will often be <i>normal</i>.</li>
      <li>In SLE, the WBC can actually be <i>low</i>, because there are antibodies against the WBCs themselves!</li>
    </ul>
  </li>
  <li><strong>Plt</strong> → will increase in inflammatory diseases, ie. <i>reactive thrombocytosis</i>.
    <ul>
      <li>In overwhelming infection (sepsis) however, one can see a significant drop in platelets, due to diffuse coagulation.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="remember"><strong>Remember</strong></h4>
  <ul>
    <li><em>WBC only rises in infectious/crystalline causes of inflammation.</em></li>
    <li><em>WBC should be normal with RA</em>, and may even fall in diseases like lupus.</li>
  </ul>
</blockquote>

<blockquote>
<h4><strong>Findings on CBC</strong></h4>
<table>
  <thead>
    <tr>
      <th style="text-align: left"> </th>
      <th style="text-align: left">Non-Inflammatory</th>
      <th style="text-align: left">Inflammatory</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td style="text-align: left">Hemoglobin</td>
      <td style="text-align: left">Normal</td>
      <td style="text-align: left"><span style="color:red">&darr;</span> (<em>Normocytic Anemia</em>)</td>
    </tr>
    <tr>
      <td style="text-align: left">WBCs</td>
      <td style="text-align: left">Normal</td>
      <td style="text-align: left">
      	<ul>
			<li>Will <span style="color:green">&uarr;</span> if infectious cause</li>
			<li>Will be <em>NORMAL</em> if RA.</li>
			<li>Can <span style="color:red">&darr;</span> if SLE</li>
      	</ul>
	   </td>
    </tr>
    <tr>
      <td style="text-align: left">Platelets</td>
      <td style="text-align: left">Normal</td>
      <td style="text-align: left">
      	<ul>
      		<li><span style="color:green">&uarr;</span> with <em>reactive Thrombocytosis</em></li>
      		<li><span style="color:red">&darr;</span> with <em>sepsis</em></li>
      	</ul>
      </td>
    </tr>
  </tbody>
</table>
</blockquote>

<h2 id="findings-with-acute-phase-reactants"><strong>Findings with Acute Phase Reactants</strong></h2>

<p><img class="right" src="/images/z7hhvi51.png" /></p>

<ul>
  <li><em>Acute Phase Reactant</em> → a protein that either <i>rises</i> or <i>falls</i> acutely, in response to a stimulation.
    <ul>
      <li>For instance, albumin and transferrin will fall in response to inflammation, while ESR and CRP will rise.</li>
      <li>The 2 ARPs that we’ll be focusing on are ESR and CRP.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-3"><strong>Objective</strong></h4>
  <ul>
    <li>What is an Erythrocyte Sedimentation Rate (ESR)?</li>
  </ul>
</blockquote>

<h3 id="erythrocyte-sedimentation-rate-esr">1. Erythrocyte Sedimentation Rate (ESR)</h3>

<ul>
  <li><strong>ESR</strong> → a measure of how quickly our blood ‘sediments’.</li>
  <li>Initially developed as a serologic test for pregnancy, but it was later found to be a useful non-specific <em>marker of inflammation</em>.</li>
  <li>The ESR isn’t a fancy test; you could do it at home!
  <img class="right" src="/images/wwo7yhht.png" />
    <ul>
      <li>Put a 200 mm long x 2.5 mm diameter tube of anticoagulated blood in a room.</li>
      <li>Set a timer for an hour.</li>
      <li>Look at how far the column of blood has fallen in an hour (mm/hr).</li>
      <li><em>Normal ESR</em>
        <ul>
          <li><em>Men</em> → Age/2.</li>
          <li><em>Women</em> → (Age + 10)/2.</li>
        </ul>
      </li>
    </ul>
  </li>
  <li><em>Why is this an inflammatory marker?</em>
    <ul>
      <li>Forces affecting the sedimentation of RBCs:
        <ul>
          <li>The size of the RBCs.</li>
          <li>Viscosity of the plasma.</li>
          <li>Repellant forces between negatively charged RBC membranes.
  <img class="right" src="/images/e_6yfe12.png" /></li>
        </ul>
      </li>
      <li>The presence of asymmetric positively charged proteins (eg. fibrinogen), which is produced with inflammation, affects the repellant force between these RBCs.</li>
      <li>These proteins allow for clumping of RBCs, allowing them to form rouleaux.</li>
      <li>This allows for the RBCs to settle more rapidly.
        <ul>
          <li>Hence, with inflammation, your blood <i>sediments more rapidly!</i></li>
        </ul>
      </li>
    </ul>
  </li>
  <li><em>We saw a condition which resulted in rouleaux formation in Blood as well → <strong>Multiple Myeloma</strong></em>
    <ul>
      <li>With multiple myeloma, which was a cancer of the plasma cells, the sharp increase in IgG antibodies also mediates rouleaux formation.</li>
      <li>Hence, the <em>ESR is very non-specific</em>; it can rise with hypergammaglobulinemia, hypoalbuminemia (recall that albumin is negatively charged), <em>pregnancy</em>, or with tissue necrosis.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-4"><strong>Objective</strong></h4>
  <ul>
    <li>What is a C-Reactive Protein (CRP)?</li>
  </ul>
</blockquote>

<h3 id="c-reactive-protein-crp">2. C-Reactive Protein (CRP)</h3>

<ul>
  <li><strong>CRP</strong> → an inflammatory protein produced by the liver under the stimulus of interleukin-6
    <ul>
      <li><em>Function</em> → able to bind to the surface of microbes and improve their removal from the body.</li>
      <li>Hence, during infection or inflammation, CRP increases in order to remove foreign microbes.</li>
      <li>Note that <em>ESR is an indirect marker of inflammation</em>, while <em>CRP is a more direct marker</em>; hence they’re not equivalent.</li>
      <li>Different things can affect CRP versus ESR.</li>
    </ul>
  </li>
  <li><em>CRP Reference Ranges</em> (not important):
    <ul>
      <li><em>Most normal people</em> → <script type="math/tex">% <![CDATA[
CRP < 2 \text{mg/L} %]]></script> (<script type="math/tex">0.2 \text{mg/dL}</script>).</li>
      <li><em>Normal range</em> → <script type="math/tex">CRP: 0-10 \text{mg/L}</script> (<script type="math/tex">1 \text{mg/dL}</script>).</li>
      <li><em>Inflammation</em> → <script type="math/tex">CRP: 10-300 \text{mg/L}</script> (<script type="math/tex">30 \text{mg/dL}</script>).</li>
    </ul>
  </li>
</ul>

<h1 id="rheumatoid-factor">Rheumatoid Factor</h1>
<hr />

<blockquote>
  <h4 id="objective-5"><strong>Objective</strong></h4>
  <ul>
    <li>Simplistically, what is the basic immunologic structure of a rheumatoid factor?</li>
  </ul>
</blockquote>

<p><img class="right" src="/images/jp0ziil_.png" /></p>

<ul>
  <li><strong>Rheumatoid Factors</strong> → Auto-antibodies directed against antigenic determinants on the Fc fragment of immunoglobulin (Ig) G molecules
    <ul>
      <li>Can be IgM, IgG, IgA, IgE <em>(IgM only routinely tested for)</em>.</li>
      <li>See previous lecture → <a href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/rheumatoid-arthritis.html">Rheumatoid Arthritis</a>.</li>
    </ul>
  </li>
  <li><em>How do we measure Rheumatoid Factor</em>
    <ol>
      <li><strong>Latex Agglutination</strong> → <em>HISTORICAL METHOD</em>.
        <ul>
          <li>This involved the use of latex particles coated with human IgG, which would <i>agglutinate</i> when patient serum was added.</li>
          <li>If there were antibodies against the IgG coated particles, then they would cause the latex particules to clump.</li>
        </ul>
      </li>
      <li><strong>Nephelometry</strong> → <em>CURRENT METHOD</em>.
 <img class="med-right" src="/images/9f8rywv0.png" />
        <ul>
          <li>More sensitive than latex agglutination.</li>
          <li>Measures the amount of scattered light when you shine a light source on the tube with the antibody-antigen complexes.</li>
          <li>Clumping would result in increased light scattering; in other words <script type="math/tex">\text{Scattered light} \propto [\text{Ab-Ag complexes}]</script>.</li>
        </ul>
      </li>
    </ol>
  </li>
</ul>

<blockquote>
  <h4 id="objective-6"><strong>Objective</strong></h4>
  <ul>
    <li>Is a rheumatoid factor is necessary to make a diagnosis of rheumatoid arthritis?</li>
    <li>How many patients with early RA and with established RA will have a rheumatoid factor?</li>
  </ul>
</blockquote>

<ul>
  <li><em>RF is NOT USEFUL in diagnosing Rheumatoid Arthritis</em>:
    <ul>
      <li>Recall that only <em>30-50%</em> of patients with early RA have a positive RF.</li>
      <li>Only <em>70-85%</em> of patients with established RA have a postiive RF.</li>
      <li>So even if the patient has a negative RF, if they fit the clinical picture, then it’s still possible that they have it!</li>
    </ul>
  </li>
  <li><em>RF does not precisely predict who will get RA</em>:
    <ul>
      <li>Asymptomatic people who happen to be RF positive are unlikely to develop RA.</li>
      <li>However, if you have a very high RF, you are at increased risk.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-7"><strong>Objective</strong></h4>
  <ul>
    <li>What does the presence of a rheumatoid factor in rheumatoid arthritis actually mean?</li>
  </ul>
</blockquote>

<ul>
  <li><em>RF does predict disease severity</em>:
    <ul>
      <li>Between 2 patients with RA, the one with the higher RF will be more likely to have an aggressive joint disease and extra-articular manifestations.</li>
      <li>Recall that extra-articular manifestations included Sicca features, Raynaud’s, CTS, rheumatoid nodules, rheumatoid vasculitis, and pleural effusions.</li>
    </ul>
  </li>
  <li><em>Following titres in someone with RA is not important</em>:
    <ul>
      <li>Levels of RF do not predict a flare.</li>
      <li>Levels of RF do not predict improvement.</li>
      <li><i>So repeat RFs are useless!</i></li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-8"><strong>Objective</strong></h4>
  <ul>
    <li>In what rheumatic and non-rheumatic diseases is a rheumatoid factor present?</li>
  </ul>
</blockquote>

<ul>
  <li><em>RF is very non-specific; it’s seen in a number of other conditions</em>:
    <ul>
      <li><i>Rheumatic</i> → Sjogren’s, SLE, MCTD, etc.</li>
      <li><i>Non-rheumatic</i> → Infection, Sacroidosis, IPF.</li>
      <li>Note that increases in RF are <em>NOT SEEN IN NORMAL AGING</em>; this is commonly seen in texts, but it’s not true!</li>
    </ul>
  </li>
</ul>

<h1 id="anti-nuclear-antibodies">Anti-Nuclear Antibodies</h1>
<hr />

<blockquote>
  <h4 id="objective-9"><strong>Objective</strong></h4>
  <ul>
    <li>Why is an anti-nuclear antibody a screening test for antibodies directed at “something” in the nucleus?</li>
  </ul>
</blockquote>

<ul>
  <li>Anti-Nuclear Antibodies are antibodies directed against “something” in the nucleus
    <ul>
      <li>However, it’s not particularly specific because there are thousands of potential antigens in the nucleus.</li>
      <li>An ANA test is looking to tell you is there an antibody directed at <i>any</i> one of these potential antigens.</li>
      <li><em>It is a screening test</em>; it’s positive in a lot of the normal population!</li>
    </ul>
  </li>
  <li><em>So when are ANAs important?</em>
    <ul>
      <li>Since ANAs are so non-specific (you see them in so many people), why is it still a useful test?</li>
      <li><em>High levels of ANA are important</em> → high titres are more significant.</li>
      <li><em>Strongly bound ANAs are important</em> → unfortunately, there’s <i>no way of measuring this</i>.</li>
      <li><i>“ANAs are like boyfriends or girlfriends. You only get in trouble when you have (1) lots of them, or (2) when they’re really clingy”.</i></li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-10"><strong>Objective</strong></h4>
  <ul>
    <li>What are ds-DNA antibodies and the antibodies in the ENA panel anti-nuclear antibodies?</li>
  </ul>
</blockquote>

<p><img class="right" src="/images/w9y-2drx.png" /></p>

<ul>
  <li><em>Some ANAs are more important than others</em>:
    <ul>
      <li>Recall that ANAs → any antibody directed at anything in the nucleus.</li>
      <li>We also have tests that can look for some specific, <i>important ANAs</i>:
        <ul>
          <li><strong>ds-DNA</strong> → antibodies directed against your double-stranded DNA.</li>
          <li><strong>ENAs</strong> (Extractable Nuclear Antigens) → a panel of antibodies that are also more significant ANAs (ENAs are assessed with suspected lupus).
            <ul>
              <li>There are 6 antibodies included in the ENA panel: <strong>Ro, La, Smith, RNP, Scl 70, Jo-1</strong>.</li>
            </ul>
          </li>
        </ul>
      </li>
    </ul>
  </li>
  <li><em>If the ANA is negative, you shouldn’t be ordering these tests!</em>
    <ul>
      <li>Obviously, the ds-DNA and the ENA are SUBTYPES of the ANA, so if the ANA is negative, these are negative by definition!</li>
      <li>It’s the equivalent of scouring a lake for fish, and upon finding none, trying to look for bass → very stupid.</li>
    </ul>
  </li>
  <li><em>How do you measure the ANA?</em>
    <ul>
      <li>Not too important; won’t be tested.</li>
      <li>Basically involves using a slide covered with cells, and exposing them to the patient serum.</li>
      <li>If ANAs bind to the nuclei of these cells, these can then be detected with fluorescently tagged antibodies against these antibodies.</li>
      <li>Since ANAs are measured by looking for fluorescence with a microscope, it’s <em>operator dependent</em> (why don’t use software to do this? beats me).</li>
      <li>You repeat this test with progressively more dilute patient serum samples, until fluorescence cannot be detected. This gives you a measure of how high the ANA levels were.</li>
      <li><em>Any dilution &gt; 1:320 is important to assess.</em>
  <img src="/images/o08r0m5y.png" /></li>
    </ul>
  </li>
  <li><em>Fluorescence patterns with ANA</em>:
    <ul>
      <li>Because ANA is assessed fluorescently, you can also see the pattern of antibody binding.</li>
      <li>This results in 6 archetypical fluorescence patterns:
  <img class="large-right" src="/images/_1rgdm5e.png" />
        <ol>
          <li><em>Homogenous</em> → most benign pattern, also most common.</li>
          <li>Rim Enhanced</li>
          <li><em>Speckled</em> → more worrying pattern.</li>
          <li>Nucleolar</li>
          <li>Centromere</li>
          <li>Cytoplasmic</li>
        </ol>
      </li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-11"><strong>Objective</strong></h4>
  <ul>
    <li>What rheumatic and non-rheumatic diseases can the ANA be present in?</li>
  </ul>
</blockquote>

<h2 id="diseases-associated-with-ve-ana"><strong>Diseases associated with +ve ANA</strong></h2>

<table>
  <thead>
    <tr>
      <th style="text-align: left">Disease</th>
      <th style="text-align: left">Percentage with a (+) ANA</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td style="text-align: left">Drug-Induced Lupus</td>
      <td style="text-align: left">100%</td>
    </tr>
    <tr>
      <td style="text-align: left">Chronic Active Hepatitis</td>
      <td style="text-align: left">100%</td>
    </tr>
    <tr>
      <td style="text-align: left"><em>Systemic Lupus Erythematosus</em></td>
      <td style="text-align: left"><em>99%</em></td>
    </tr>
    <tr>
      <td style="text-align: left">Systemic Sclerosis</td>
      <td style="text-align: left">95%</td>
    </tr>
    <tr>
      <td style="text-align: left">Mixed Connective Tissue Disease</td>
      <td style="text-align: left">95-99%</td>
    </tr>
    <tr>
      <td style="text-align: left">Polymyositis/Dermatomyositis</td>
      <td style="text-align: left">90%</td>
    </tr>
    <tr>
      <td style="text-align: left">Sjogren’s Syndrome</td>
      <td style="text-align: left">80%</td>
    </tr>
    <tr>
      <td style="text-align: left">Rheumatoid Arthritis</td>
      <td style="text-align: left">60%</td>
    </tr>
    <tr>
      <td style="text-align: left">Myasthenia Gravis</td>
      <td style="text-align: left">50%</td>
    </tr>
    <tr>
      <td style="text-align: left">Diabetes</td>
      <td style="text-align: left">25%</td>
    </tr>
  </tbody>
</table>

<blockquote>
  <h4 id="objective-12"><strong>Objective</strong></h4>
  <ul>
    <li>Are patients with a negative ANA unlikely to have systemic lupus erythematosus?</li>
  </ul>
</blockquote>

<ul>
  <li><em>A NEGATIVE ANA is very effective at ruling out Lupus</em>:
    <ul>
      <li>Since basically 100% of patients with lupus have a positive ANA, if you get a negative ANA with a suspected patient, <em>they don’t have lupus</em>.</li>
      <li>Hence, since ANA is so specific, it’s very good at ruling out diseases!</li>
    </ul>
  </li>
</ul>

<h1 id="other-antibodies">Other Antibodies</h1>
<hr />

<h2 id="anti-double-stranded-dna">1. <strong>Anti-Double Stranded DNA</strong></h2>

<p><img class="right" src="/images/v3zf9-gz.png" /></p>

<ul>
  <li><strong>Anti-ds-DNA</strong> (often referred to as ds-DNA), is a specific ANA that’s <em>very specific for Lupus</em>.
    <ul>
      <li>So unlike ANA, which is sensitive but not specific, ds-DNA is very specific!</li>
      <li>As mentioned before, if the ANA is negative, the ds-DNA will be negative.</li>
      <li><em>Always do the ANA first, and if that’s positive, then do the ds-DNA</em>!</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-13"><strong>Objective</strong></h4>
  <ul>
    <li>Do all patients with SLE have to have a positive ds-DNA?</li>
  </ul>
</blockquote>

<ul>
  <li><em>If a patient has a <i>high-titer</i> positive ds-DNA then they are likely to have SLE (&gt;90%)</em>
    <ul>
      <li>However, <strong>a negative ds-DNA does not rule out SLE</strong>.</li>
      <li>In London only about 50% with definite SLE have a positive ds-DNA.
        <ul>
          <li>In literature, this ranges from 60-83%.</li>
        </ul>
      </li>
      <li>In some patients with SLE, rising titers of ds-DNA may be associated with a flare.</li>
    </ul>
  </li>
</ul>

<h2 id="extractable-nuclear-antigens">2. <strong>Extractable Nuclear Antigens</strong></h2>

<ul>
  <li><strong>ENAs</strong> were another subset of ANAs, as mentioned previously.
    <ul>
      <li>These are <em>6 antibodies</em> which correlate to a higher degree with certain disease states.</li>
      <li>So, as mentioned before, if ANA is negative, ENA is negative.</li>
    </ul>
  </li>
  <li><em>The 6 antibodies in the ENA panel are</em>:
    <ol>
      <li><em>Ro</em> (SSA).</li>
      <li><em>La</em> (SSB).</li>
      <li><em>Smith</em> (Sm).</li>
      <li><em>RNP</em></li>
      <li><em>Scl 70</em> (Topoisomerase-I).</li>
      <li><em>Jo-1</em> (Histidyl tRNA-syntetase).</li>
    </ol>
  </li>
  <li>When you do an ENA test, they’ll first look for the presence/absence of any of the ENAs, and if any are present, they will then do the levels.</li>
  <li>The disease associations for each antibody are listed below (<em>YOU DO NOT NEED TO KNOW THIS FOR THE EXAM</em>).</li>
</ul>

<blockquote>
  <h4 id="ena-disease-associations"><strong>ENA Disease Associations</strong></h4>

  <table>
    <thead>
      <tr>
        <th style="text-align: left">Antibody</th>
        <th style="text-align: left">Disease Association</th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td style="text-align: left">SSA/Ro</td>
        <td style="text-align: left">SS, SCLE, NLE, SLE</td>
      </tr>
      <tr>
        <td style="text-align: left">SSB/La</td>
        <td style="text-align: left">SS, SCLE, NLE, SLE</td>
      </tr>
      <tr>
        <td style="text-align: left">Smith (Sm)</td>
        <td style="text-align: left">SLE</td>
      </tr>
      <tr>
        <td style="text-align: left">RNP</td>
        <td style="text-align: left">MCTD, SLE</td>
      </tr>
      <tr>
        <td style="text-align: left">Scl 70 (Topoisomerase-I)</td>
        <td style="text-align: left">Diffuse SSc</td>
      </tr>
      <tr>
        <td style="text-align: left">Jo-1 (Histidyl-tRNA-synthetase)</td>
        <td style="text-align: left">PM/DM</td>
      </tr>
    </tbody>
  </table>

  <ul>
    <li><em>SS</em> → Sjogren’s Syndrome.</li>
    <li><em>SCLE</em> → Subacute Cutaneous Lupus.</li>
    <li><em>NLE</em> → Neonatal Lupus.</li>
    <li><em>MCTD</em> → Mixed Connective Tissue Disease.</li>
    <li><em>SSc</em> → Systemic Sclerosis.</li>
    <li><em>PM</em> → Polymyositis.</li>
    <li><em>DM</em> → Dermatomyositis.</li>
  </ul>
</blockquote>

<h2 id="anti-neutrophil-cytoplasmic-antibody">3. <strong>Anti-Neutrophil Cytoplasmic Antibody</strong></h2>

<blockquote>
  <h4 id="objective-14"><strong>Objective</strong></h4>
  <ul>
    <li>What is an ANCA, what are the two types, and what diseases is it associated with?</li>
  </ul>
</blockquote>

<ul>
  <li><strong>ANCAs</strong> → <em>Anti-Neutrophil Cytoplasmic Antibodies</em>.
    <ul>
      <li>These are a collection of antibodies directed against components of neutrophil granules.</li>
      <li><em>These are related to vasculitis</em>; a strong ANCA is a good surrogate marker of <em>small vessel vasculitis.</em></li>
      <li>However, the diagnosis of this must be confirmed by histopathologic findings on biopsy.</li>
    </ul>
  </li>
  <li><em>There are 2 types of ANCAs</em>
    <ol>
      <li><strong>c-ANCA</strong>.</li>
      <li><strong>p-ANCA</strong>.</li>
    </ol>
  </li>
  <li>As we saw a very long time ago, in GU, these were associated with the <em>Classical Systemic Vasculitis Diseases</em>, which could cause nephritic syndrome:
    <ol>
      <li><strong>Wegener’s Granulomatosis</strong> → <em>c-ANCA</em>
        <ul>
          <li>Recall that this was renamed to <em>GPA</em>: <em>Granulomatosis with Polyangiitis</em>; one of the reasons was because Dr. Friedrich Wegener was a nazi, and may have experimented on concentration camp inmates.</li>
        </ul>
      </li>
      <li><strong>Microscopic Polyangiitis</strong> (MPA) → <em>p-ANCA</em>.</li>
      <li><strong>Churg-Strauss Syndrome</strong> (CSS) → <em>c-ANCA or p-ANCA</em>.
        <ul>
          <li>As with Wegener’s this was renamed to <em>EGPA</em>: <em>Eosinophilic Granulomatosis with Polyangiitis</em>, although neither of these physicians were as controversial.</li>
        </ul>
      </li>
    </ol>
  </li>
</ul>

<blockquote>
  <h4 id="remember-1"><strong>Remember</strong></h4>
  <ul>
    <li><em>Wegener’s Granulomatosis</em> → <em>c-ANCA</em>.</li>
    <li><em>Microscopic Polyangiitis</em> → <em>p-ANCA</em>.</li>
    <li><em>Churg-Strauss</em> → <em>c-ANCA or p-ANCA</em>.</li>
    <li>Of these, the <i>scariest</i> (ie. most predictive), is <em>c-ANCAs for Wegener’s</em>.</li>
  </ul>
</blockquote>

<ul>
  <li><em>However, these disease associations aren’t completely sensitive or specific.</em>
    <ul>
      <li>c-ANCA is 98% specific for Wegener’s, but is only 40-95% sensitive depending on disedase activity.</li>
      <li>This is similar with the other vasculitides.</li>
      <li>Hence, although strong ANCA activity is a good surrogate, it must fit within a good clinical context.</li>
      <li>As mentioned before, the only definitive diagnosis is by <em>biopsy</em>.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-15"><strong>Objective</strong></h4>
  <ul>
    <li>What antibodies are c-ANCA and p-ANCA a result of?</li>
  </ul>
</blockquote>

<ul>
  <li><strong>c-ANCA</strong> → caused by <em>anti-proteinase 3</em> <strong>(PR3)</strong>.</li>
  <li><strong>p-ANCA</strong> → caused by <em>anti-myeloperoxidase</em> <strong>(MPO)</strong>.</li>
  <li>In London hospitals now, c-ANCA and p-ANCA are reported as PR3 and MPO respectively.</li>
</ul>

<h2 id="complement">4. <strong>Complement</strong></h2>

<ul>
  <li>It is named “complement system” because it was first identified as a heat-labile component of serum that “complemented” antibodies in the killing of bacteria.
    <ul>
      <li>It is now known that it consists of over 30 proteins and contributes 3 g/L to overall serum protein quantities.</li>
    </ul>
  </li>
  <li><em>There are 2 pathways through which it’s activated</em>:
  <img class="right" src="/images/kyploo9v.png" />
    <ul>
      <li><strong>Classical Pathway</strong> → activated through antibody binding to foreign material.</li>
      <li><strong>Alternative Pathway</strong> → activated through binding of one specific complement protein (C3b) to foreign material.
        <ul>
          <li>The alternative pathway is actually downstream of the classical pathway; activation of the classical pathway involves the proteins of the alternative pathway.</li>
        </ul>
      </li>
      <li>The ultimate result of the complement system is the activation of the <em>Membrane Attack Complex</em> (MAC).</li>
    </ul>
  </li>
  <li><em>The complement system has a number of functions</em>:
    <ul>
      <li><em>Opsonization</em> → enhances phagocytosis.</li>
      <li><em>Chemotaxis</em> → attracts other inflammatory cells.</li>
      <li><em>Increases vasodilation &amp; permeability</em> → allows other inflammatory cells to enter a region more easily.</li>
      <li><em>Cellular lysis</em> → activation of the MAC helps destroy offending cells.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-16"><strong>Objective</strong></h4>
  <ul>
    <li>Why do some patients with connective tissue disorders and vasculitis have a low complement level?</li>
  </ul>
</blockquote>

<ul>
  <li><em>Complement is important to measure because it can be INAPPROPRIATELY expended in some diseases</em>:
    <ul>
      <li>For instance, in SLE (lupus, which is a connective tissue disorder), the body’s immune system becomes confused, and actually <em>attacks healthy tissue</em>.</li>
      <li>Since auto-antibodies are formed, when these antibodies bind to our tissue, it can activate the complement system via the classical pathway.</li>
      <li>This results in the <em>consumption of complement proteins</em>, as they’re being used to attack our own body. This is reflected in a <em>low complement</em>.</li>
      <li>As a result, we <em>always measure complement levels in diseases like SLE</em>.</li>
    </ul>
  </li>
</ul>
                
                </div>
            </div>
            <div class="pagination">
                <div style="width:50%; float:left;">
                     
                        <a class="newer" href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/rheumatoid-arthritis.html"><i class="fa fa-angle-left"></i> Rheumatoid Arthritis</a> 
                     
                </div>
                <div style="width:50%; float:right;">
                     
                        <a class="older" href="http://www.schulichnotes.com/musculoskeletal/2015/02/20/connective-tissue-disorders-1.html">Connective Tissue Disorders I <i class="fa fa-angle-right"></i></a> 
                     
                </div>
            </div>
        </div>
    </div>
    <script src="http://www.schulichnotes.com/musculoskeletal/index.js" type="text/javascript"></script>
<link rel="stylesheet" href="/resources/stylesheets/search.css">	
<script src="/resources/libraries/tipuesearch_set.js" type="text/javascript"></script>
<script src="/resources/libraries/tipuesearch.js" type="text/javascript"></script>
<script src="/resources/libraries/classie.js" type="text/javascript"></script>
<script>
var search = document.getElementById('header-search-icon');
var searchbar = document.getElementById('header-search-bar');
search.onclick = function(){classie.toggle(searchbar, 'search-bar-open');}
$(document).ready(function() {$('#tipue_search_input').tipuesearch();});
</script>
</body>
</html>